Isolated neural lobes of the rat pituitary gland were incubated in Krebs-HEPES solution which contained the dopamine uptake inhibitor GBR 12921 and in some experiments additionally pargyline. The release of endogenous dopamine evoked by electrical stimulation of the pituitary stalk was determined by high-performance liquid chromatography with electrochemical detection. (*)-Naloxone increased the evoked dopamine release maximally by 440% (EC,, 209 nM). The (+)-enantiomer of naloxone (up to 10 pM) did not affect the release of dopamine. The preferential rc-opioid receptor antagonist M R 2266 increased the evoked dopamine release maximally by 135% (EC,, 7 nM). M R 2267, the inactive (+)-enantiomer of M R 2266, had no effect on dopamine release. The 8-opioid receptor selective antagonist ICI 174864 increased the release of dopamine maximally by 120% (EC,, 10 nM). The nonselective opioid receptor agonist etorphine up to 10 pM had no effect on the evoked dopamine release. In conclusion, endogenous opioids in the neurohypophysis strongly inhibit the release of endogenous dopamine from this gland. Activation of K-and 8-opioid receptors appears to be involved in the inhibitory action of the endogenous opioids on the neurohypophysial release of dopamine.The rat neurohypophysis contains, beside the classical neurohormones vasopressin and oxytocin, a number of other biologically active neuropeptides and neurotransmitters. Thus, dopaminergic and noradrenergic nerve fibres innervate this gland (1-4). There is considerable evidence that dopamine and noradrenaline may play a significant role as local modulators of the release of vasopressin and oxytocin (4-9). In addition, different opioid peptides are present in the neurohypophysis in high concentrations. They appear to be co-localized with the neurohormones in the neurosecretory nerve endings, those derived from pro-dynorphin with vasopressin and those derived from pro-enkephalin with oxytocin (10-13). In addition, depolarizing stimuli which are known to induce the release of vasopressin and oxytocin (14-16) also evoke the release of the opioid peptides Since the opioid receptor antagonist naloxone increased the release of vasopressin (20, 21) and particularly that of oxytocin (21-28), it was concluded that the endogenous opioids in the neurohypophysis may modulate directly the release of these neurohormones. Furthermore, these opioids also appear to inhibit the release of noradrenaline and dopamine in this gland, since naloxone also enhanced the electrically-evoked release of [3H]-noradrenaline (2 I ) and that of endogenous dopamine (29) from the isolated neurohypophysis. Thus, the endogenous opioids in (1 7-19).the neurohypophysis appear to control the release of several neurotransmitters and neurohormones.It is now clear that opioid receptors consist of several subtypes (30). Therefore, it appears possible that the different opioid peptides in the neurohypophysis may modulate the release of the neurohormones and that of the catecholamines via different opioid recep...